Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy
Impaired apoptotic clearance of myofibroblasts can result in the continuous expansion of scar tissue during the persistent injury in the lung. However, the molecular and cellular mechanisms underlying the apoptotic clearance of multiple mesenchymal cells including fibrocytes, fibroblasts and myofibr...
Main Authors: | Rajesh K. Kasam, Geereddy B. Reddy, Anil G. Jegga, Satish K. Madala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00532/full |
Similar Items
-
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
by: Seidai Sato, et al.
Published: (2017-09-01) -
Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis
by: Rajesh K Kasam, et al.
Published: (2020-09-01) -
Consensus Gene Co-Expression Network Analysis Identifies Novel Genes Associated with Severity of Fibrotic Lung Disease
by: Sudhir Ghandikota, et al.
Published: (2022-05-01) -
The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis
by: Dan J. K. Yombo, et al.
Published: (2021-03-01) -
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
by: Maurizio Cutolo, et al.
Published: (2021-08-01)